ABT Price Prediction Next Week
Technical Analysis: Based on the latest data, ABT closed at $134.92 on Friday, showing a +1.31% gain and outperforming the broader market. The stock has demonstrated strong momentum, climbing 8.07% over the past month.
The technical indicators show:
- RSI (14) at 70.98 indicates approaching overbought territory but still has room to run
- Stochastic oscillator (14,3,3) at 95.15 suggests strongly overbought conditions
- MACD is positive at 3.64 with a slight bearish divergence (-0.02 histogram)
- Trading above all major moving averages (5,10,20,60,200-day)
- Currently trading near the upper Bollinger Band (136.68), suggesting strong momentum
News Analysis:
- Positive fundamental outlook with Peter Lynch-based model giving ABT a 91% rating
- FDA's recent workforce adjustments affecting medical device division could create short-term uncertainty
- Strong Q4 performance with expectations of continued growth
Price Prediction for Next Week: Based on Fibonacci levels and technical indicators:
- Resistance levels: $136.20 (R2), $139.00 (R3)
- Support levels: $131.66 (Pivot), $128.86 (S1)
Most likely scenario: ABT is likely to experience a minor pullback early in the week due to overbought conditions, finding support around $131.66, before continuing its upward trend. Target range: $136-137.
Trading Recommendation: SELL with the following strategy:
- Entry: Current price ($134.92)
- Take profit: $131.66 (Pivot level)
- Stop loss: $136.20 (R2 level)
Rationale: The combination of overbought technical indicators and strong recent gains suggests a higher probability of a short-term pullback. The stock has reached a resistance zone and shows signs of momentum exhaustion.
ABT Similar Chart Price Prediction
The price of ABT is predicted to go up 4.2%, based on the high correlation periods with TFX. The similarity of these two price pattern on the periods is 98.86%.
ABT
TFX
Up: 4.2%Similarity: 98.86%
ABT Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030
Year
ABT Price Forecast($)
Potential Return(%)
2025
113.930
0.090
2026
145.000
13.340
2027
160.000
25.070
2028
160.000
25.070
2029
175.000
36.790
2030
180.000
40.700
What is ABT stock price prediction 2025 ?
What is ABT stock price prediction 2026 ?
What is ABT stock price prediction 2027 ?
What is ABT stock price prediction 2028 ?
What is ABT stock price prediction 2029 ?
What is ABT stock price prediction 2030 ?
ABT Revenue Forecast
ABT EPS Forecast
ABT FAQs
What is bull’s view on ABT?
What is bear's view on ABT?
What is ABT revenue forecast for next quarter？
What is ABT eps forecast for next quarter？
ABT VS S&P500
Abbott has been investing in structural heart products and recently entered the left atrial appendage closure market.
Early results from an investigational clinical trial on the Tendyne transcatheter mitral valve were favorable. If the pivotal trial results are favorable, this could give a boost to Abbott's structural heart unit.
Abbott's sale of its established pharma business in developed markets to Mylan and its acquisition of CFR and Veropharm have put the branded generics business in a strong position to benefit from growing demand in emerging markets.
ABT Analyst's Forecast
Rick Wise
Stifel
Strong Buy
2025-01-23
Price Target
$130 → $135
Upside
+10.54%
Stifel raised the firm's price target on Abbott to $135 from $130 and keeps a Buy rating on the shares. The firm views Abbott's Q4 results and the 2025 set-up "positively," arguing that momentum in the company's Diabetes Care business and Structural Heart business "appears primed to drive another year of double-digit Medical Device division growth" and high-single-digit total company growth, the analyst tells investors in a post-earnings note.
Danielle Antalffy
UBS
Strong Buy
2025-01-23
Price Target
$146 → $148
Upside
+21.18%
Matt Miksic
Barclays
Buy
2024-11-05
Price Target
$143 → $149
Upside
+26.74%
